Medical News

RSS

Clinical and scientific advances made in the field of neuro-oncology

Many important clinical and basic scientific advances have been made in the past five years in the field of neuro-oncology, according to an editorial and several articles in the March issue of Archives of Neurology, one of the JAMA/Archives journals.

9 Mar 2010

Viatronix V3D-Colon software used for the President's colon cancer screening exam

Viatronix Incorporated, a Stony Brook, New York, based company announced that its V3D-Colon software is used at the National Naval Medical Center where the President's annual physical was done. "Our software is being utilized at several DOD facilities since the landmark Virtual Colonoscopy clinical trial published in the New England Journal of Medicine back in December 2003," said Zaffar Hayat, President of Viatronix Incorporated.

9 Mar 2010

Blue Care Networks of Michigan abandons its attempt to purchase PHP of Mid-Michigan

Blue Cross Blue Shield of Michigan's subsidiary, Blue Care Networks of Michigan, abandoned its attempt to purchase Physicians Health Plan of Mid-Michigan after the Department of Justice informed the companies that it would file an antitrust lawsuit to block the acquisition.

9 Mar 2010

Harvard University, Dana-Farber Cancer Institute complete major licensing agreement with Acetylon

Harvard University and Dana-Farber Cancer Institute announced today that they have concluded a major licensing agreement with Acetylon under which Harvard and Dana-Farber granted an exclusive therapeutic license to a robust platform technology and chemical methodology that enables high-throughput screening and lead optimization for HDAC inhibitor compounds.

9 Mar 2010

Black and Hispanic Medicare beneficiaries with heart failure less likely to receive hospice care

Black and Hispanic Medicare beneficiaries with heart failure appear less likely to receive hospice care than white patients with the same condition, according to a report in the March 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

9 Mar 2010

Some anti-depressant drugs associated with increased chance of developing cataracts: Study

Some anti-depressant drugs are associated with an increased chance of developing cataracts, according to a new statistical study by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute and McGill University.

9 Mar 2010

CNA: Federal budget - a missed opportunity to initiate much-needed transformation of health system

The Canadian Nurses Association feels that the federal budget does not go far enough at what it sees as a critical juncture for health care in Canada.

9 Mar 2010

JAAD publishes Phase III data evaluating safety and efficacy of imiquimod in patients with AK

The Journal of the American Academy of Dermatology has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses – 2.5% and 3.75% – administered daily on either 2-week or 3-week treatment cycles.

9 Mar 2010

Haitian President to meet with Obama as long-term rebuilding plans take shape

Haitian President Rene Preval is expected to meet with President Barack Obama Wednesday in the U.S. to ask for "billions of dollars to rebuild" Haiti, Agence France-Presse reports.

9 Mar 2010

Consumer Watchdog calls for national freeze on health insurance rates and rate regulation

Consumer Watchdog called on President Obama to impose a national freeze on health insurance rates before health reform takes effect to protect consumers from premium hikes like the 39% increase recently announced by Anthem Blue Cross in California. The rate freeze is one of five tools Consumer Watchdog urged the president to include as part of his proposed fixes to the Senate health care bill.

9 Mar 2010

RepRegen's Strontium-based bioactive glass platform encourages osteoblast cell activity and proliferation

RepRegen™, the ‘smart biomaterials’ company previously known as BioCeramic Therapeutics, announced today that data from an in vitro study has demonstrated that its patented Strontium-based bioactive glass platform promotes osteoblast cell activity and proliferation. If in vivo studies, which are currently underway, demonstrate similar results, then RepRegen believes its platform has the potential to significantly improve the repair and regeneration of hard-tissue, such as bone.

9 Mar 2010

Gannett offers promotional support to ClearChoice Dental Implant Centers to help military members and veterans

Gannett is offering promotional support to ClearChoice Dental Implant Centers, the No. 1 dental implant provider in the U.S., to help current members of the military and military veterans who have developed dental problems related to their service.

9 Mar 2010

Herceptin as add-on to standard chemotherapy for gastric cancer earns Decision Resources' gold standard status

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of gastric cancer, Roche/Genentech/ Chugai's Herceptin as an add-on to standard chemotherapy earns Decision Resources' proprietary clinical gold standard status in 2013, following its approval for the first-line treatment of human epidermal growth factor receptor 2 (HER2)-positive gastric cancer in 2010.

9 Mar 2010

Abused children more likely to suffer abdominal pain and nausea

Children who have been abused psychologically, physically or sexually are more likely to suffer unexplained abdominal pain and nausea or vomiting than children who have not been abused, a study led by University of North Carolina at Chapel Hill researchers concludes.

9 Mar 2010

MDS ends strategic repositioning with divestiture of MDS Pharma Services Early Stage business

MDS Inc., a leading provider of products and services to the global health sciences markets, today announced that it has completed the divestiture of its MDS Pharma Services Early Stage business.

9 Mar 2010

Chicago Female Condom Campaign: Educating women about HIV/AIDS and FC2 Female Condom

The Female Health Company is supporting the launch of a social marketing campaign in Chicago that will educate women about HIV/AIDS and boost awareness, availability, and access to the FC2 Female Condom®, the only FDA approved woman-initiated HIV prevention method currently available.

9 Mar 2010

Positive results from INSYS Therapeutics' phase III trial for Fentanyl SL Spray

INSYS Therapeutics, Inc. announces positive results from the pivotal phase III efficacy trial for patients utilizing the Fentanyl Sublingual Spray technology to treat breakthrough cancer pain. All primary and secondary endpoints were achieved in the study, and the drug is the first product to ever show statistically significant pain relief when measuring the summary of pain intensity difference at five minutes in a phase III breakthrough cancer pain trial using Fentanyl.

9 Mar 2010

BIO-key International's accuracy improves by 23% on DHS2 Dataset

BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced that in the recent test results published by the National Institute of Standards and Technology (NIST), BIO-key's accuracy improved by a remarkable 23% on the DHS2 Dataset.

9 Mar 2010

Well-characterized molecular alterations of sarcomas make them ideal models for developing new therapies

New breakthrough treatments for the most common cancers could soon come from cutting-edge research into some of the world's rarest tumors.

9 Mar 2010

Study suggests early warning signs for autism spectrum disorders within families

A new study suggests a trend toward developing hyperactivity among typically developing elementary-school-aged siblings of autistic preschoolers and supports the notion that mothers of young, autistic children experience more depression and stress than mothers with typically developing children.

9 Mar 2010

Medical News

Clinical and scientific advances made in the field of neuro-oncology

Viatronix V3D-Colon software used for the President's colon cancer screening exam

Blue Care Networks of Michigan abandons its attempt to purchase PHP of Mid-Michigan

Harvard University, Dana-Farber Cancer Institute complete major licensing agreement with Acetylon

Black and Hispanic Medicare beneficiaries with heart failure less likely to receive hospice care

Some anti-depressant drugs associated with increased chance of developing cataracts: Study

CNA: Federal budget - a missed opportunity to initiate much-needed transformation of health system

JAAD publishes Phase III data evaluating safety and efficacy of imiquimod in patients with AK

Haitian President to meet with Obama as long-term rebuilding plans take shape

Consumer Watchdog calls for national freeze on health insurance rates and rate regulation

RepRegen's Strontium-based bioactive glass platform encourages osteoblast cell activity and proliferation

Gannett offers promotional support to ClearChoice Dental Implant Centers to help military members and veterans

Herceptin as add-on to standard chemotherapy for gastric cancer earns Decision Resources' gold standard status

Abused children more likely to suffer abdominal pain and nausea

MDS ends strategic repositioning with divestiture of MDS Pharma Services Early Stage business

Chicago Female Condom Campaign: Educating women about HIV/AIDS and FC2 Female Condom

Positive results from INSYS Therapeutics' phase III trial for Fentanyl SL Spray

BIO-key International's accuracy improves by 23% on DHS2 Dataset

Well-characterized molecular alterations of sarcomas make them ideal models for developing new therapies

Study suggests early warning signs for autism spectrum disorders within families

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News